Index trend and stocks in action October 09, 2019
Index trend and stocks in action October 09, 2019

Index trend and stocks in action October 09, 2019

Karan Dsij Article rating: 5.0

If Nifty falls below the 11,060 level, the next level support is placed at 10,890. Below this, there are chances it may test the prior lows.On the upside, the immediate resistance is placed at 200 DMA (11,264) and only by moving above this level will the bulls get confidence to move higher.

Glenmark Pharmaceuticals plummets on US FDA warning letter
Glenmark Pharmaceuticals plummets on US FDA warning letter

Glenmark Pharmaceuticals plummets on US FDA warning letter

Amir Shaikh Article rating: 5.0

Glenmark Pharmaceuticals has informed the bourses that US FDA has issued a warning letter for its Baddi facility at Himachal Pradesh. The said facility was inspected by US FDA during 15th to 20th April of 2019. 

Indoco Remedies gets USFDA approval for its Rasagiline ANDA
Indoco Remedies gets USFDA approval for its Rasagiline ANDA

Indoco Remedies gets USFDA approval for its Rasagiline ANDA

Apurva Joshi Article rating: 5.0

Indoco Remedies Limited has received the final approval for its Abbreviated New Drug Application (ANDA) for Rasagiline 0.5 mg and 1 mg tablets from the United States Food & Drug Administration (USFDA).

P2P Lending as an asset class: Should you cherish it?
P2P Lending as an asset class: Should you cherish it?

P2P Lending as an asset class: Should you cherish it?

Henil Shah Article rating: 4.0

There are various asset classes available in the market today. Now P2P lending has made its way to become one of them. So, should you consider investing via P2P lending? Let’s find out.

Index trend and stocks in action October 07, 2019
Index trend and stocks in action October 07, 2019

Index trend and stocks in action October 07, 2019

Karan Dsij Article rating: 5.0
Now going ahead, bulls will set sight on the next crucial support level of 11,074 as it is a 61.8 per cent retracement of the recent upsurge and also the 50-DMA is placed near this level. On the upside, the 200-DMA, which is placed at 11,262, would now act as a stiff resistance for the bulls. The daily relative strength index is in falling trajectory and features in the neutral zone, the next crucial level to watch out is around 38-40 mark.
Flat start likely for the markets
Flat start likely for the markets

Flat start likely for the markets

Karan Dsij Article rating: 5.0
After days of relentless correction, bulls can finally heave a sigh of relief on Monday at least at the opening bell as early cues from SGX Nifty is indicating markets may began the session in the green, however, the gains are miniscule as SGX is trading with an uptick of 8 points at 11,214 levels. The week gone by was the worst week for the markets since May. 
Lupin launches Mycophenolate Mofetil Capsules
Lupin launches Mycophenolate Mofetil Capsules

Lupin launches Mycophenolate Mofetil Capsules

Shohini Nath Article rating: 5.0

Lupin has launched Mycophenolate Mofetil Capsules USP, 250 mg. The shares could be in focus on the following trading day as a reaction to the launch.


Uflex closes in green on divesting stake in Utech Developers
Uflex closes in green on divesting stake in Utech Developers

Uflex closes in green on divesting stake in Utech Developers

Shohini Nath Article rating: 5.0

Uflex has completed the sale of its 82 per cent stake in Utech Developers on October 3, 2019. Post the news the shares gained over 1 per cent but lost steam at closing hours although in green.


RSS
First25062507250825092511251325142515Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR